NYU Langone Health wants to enroll 1,000 people for a COVID-19 clinical trial, made by pharmaceutical firm AstraZeneca. It's part of a larger, 30,000-person trial of the vaccine being conducted across the globe. Credit: NYU Langone Health

SUBSCRIBE

Unlimited Digital AccessOnly 25¢for 6 months

ACT NOWSALE ENDS SOON | CANCEL ANYTIME